18F-FDOPA now available
Fluorodopa (18F) is now available for clinical studies and - with doctor's certificate - for routine patient care. This product is indicated for use in Positive Emission Tomography (PET) in adults and children.
It is used in the diagnosis of various neurological disorders (such as Parkinson's disease), but also in the imaging of specific neuroendocrine tumors.
Neurology
PET with fluorodopa (18F) is indicated to demonstrate a loss of functional dopaminergic nerve endings in the striatum. Defects in dopamine housings are associated with various neurological disorders such as Parkinson's disease. It is therefore used to distinguish essential tremor from parkinsonistic syndromes related to degenerative disorders of the nigrostriatal system (Parkinson's disease, multiple system atrophy and progressive supranuclear palsy).
Oncology
Studies on imaging research show that PET with fluorodopa (18F) allows for a functional approach of pathologies, organs or tissues looking for an increase in intracellular transport and decarboxylation of the amino acid dihydroxyphenylalanine.
Interested in 18F-FDOPA? Contact us to discuss the possibilities.
![18F-FDOPA now available](https://radboudtranslationalmedicine.nl/cdn/dde0a2a7-a571-4ff2-924d-3fd7f3a0878f/-/resize/555x/-/format/auto/-/quality/smart/041radboud-ossip.jpg)
Other news
![First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer](https://radboudtranslationalmedicine.nl/cdn/6bac4557-a1f4-4d63-9b07-9644f2141bfa/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-nieuwsbericht.jpg)
First Patient Dosed in Phase II Study of TLX250-CDx in Triple-Negative Breast Cancer
The below product is manufactured at RTM First Patient Dosed in Phase II Study of TLX250-CDx in Tri...
![GMP-certificate received](https://radboudtranslationalmedicine.nl/cdn/d8e82eeb-ebb5-4876-a874-f2bd22bd1425/-/crop/433x294/7,-14/-/smart_resize/250x170/-/scale_crop/250x170/smart/-/format/auto/-/quality/smart/logo-igz.png)
GMP-certificate received
Today we received our GMP-certificate!The results of the inspection were excellent and no shortcomin...
![RTM added as distributor NeuraCeq®](https://radboudtranslationalmedicine.nl/cdn/c23b15a6-eef5-4843-a143-f51c61ba0b6a/-/smart_resize/250x170/-/format/auto/-/quality/smart/neuraceq.png)
RTM added as distributor NeuraCeq®
Exciting news! Life Molecular Imaging’s NeuraCeq® 300 MBq/ml solution for injection (florbetaben 18F...
![First Patient Dosed with TLX250-CDx in Italy for ccRCC](https://radboudtranslationalmedicine.nl/cdn/45d80979-3021-4c1a-aec1-225f1cfcea01/-/smart_resize/250x170/-/format/auto/-/quality/smart/telix-first-patient-dose-italy.png)
First Patient Dosed with TLX250-CDx in Italy for ccRCC
The below product is manufactured at RTM First Patient dosed with TLX250-CDx in Italy for ccRCC Th...
Interested in a collaboration?
Contact us to discuss the possibilities.